This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

This study has suspended participant recruitment.
Sponsor:
Information provided by (Responsible Party):
Olivera Finn, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01720836
First received: October 31, 2012
Last updated: July 25, 2017
Last verified: July 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: February 2022
  Estimated Primary Completion Date: February 2019 (Final data collection date for primary outcome measure)